Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Berries—particularly blueberries, strawberries, and blackberries—are rich in polyphenols such as anthocyanins and flavonoids, which have been investigated for their potential neuroprotective effects. Several preclinical studies in animal models of Alzheimer’s Disease (AD) have shown that berry extracts may reduce oxidative stress, modulate inflammation, and improve cognitive performance. For example, research using blueberry supplementation in aged animals has demonstrated an improvement in spatial working memory and a reduction in amyloid-beta accumulation, a hallmark of AD pathology.

Human evidence is more limited. Some epidemiological studies suggest that higher berry consumption correlates with slower rates of cognitive decline in older adults. Small randomized controlled trials have found that berry supplementation may improve certain cognitive functions in older individuals, but these studies are generally short-term and use healthy populations or those with mild cognitive impairment rather than diagnosed AD.

Currently, there is no robust clinical evidence that berry extracts or “berry flavor” can treat or halt the progression of Alzheimer’s Disease. The use of berry-derived compounds is based on their antioxidant and anti-inflammatory properties, which are theoretically relevant to AD pathology. While the scientific rationale exists and preclinical results are promising, human trials are limited in scope and quality. Thus, the evidence supporting the use of berry flavor or extracts for AD is preliminary (rated 2/5), and further large-scale, long-term clinical trials are needed to confirm efficacy.

More about berry flavor
More about Alzheimer's Disease

Other ingredients used for Alzheimer's Disease

Other health conditions supported by berry flavor

Products containing berry flavor